Current Drug Targets - Cardiovascular & Hematological Disorders
Title: Preface
Volume: 3 Issue: 1
Author(s): Alexandra Lucas
Affiliation:
Export Options
About this article
Cite this article as:
Lucas Alexandra, Preface, Current Drug Targets - Cardiovascular & Hematological Disorders 2003; 3 (1) . https://dx.doi.org/10.2174/1568006033337320
DOI https://dx.doi.org/10.2174/1568006033337320 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
7
Related Articles
-
The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices
Current Pharmaceutical Design Resisting the Sun with Vitamin D
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models
Current Vascular Pharmacology Effect of Inhibitors of Nitric Oxide in Animal Models and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Effect of Risk Factor Changes on Peripheral Arterial Disease and Cardiovascular Risk
Current Drug Targets - Cardiovascular & Hematological Disorders Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Preface
Current Cardiology Reviews Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination
Current Hypertension Reviews The Pharmacologic Approach to the Prevention of Preeclampsia: From Antiplatelet, Antithrombosis and Antioxidant Therapy to Anticonvulsants
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Current Inhibition Concepts of Zinc Metallopeptidases Involved in Blood Pressure Regulation
Current Enzyme Inhibition Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?
Cardiovascular & Hematological Agents in Medicinal Chemistry The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension
Vascular Disease Prevention (Discontinued) A Systematic Review of Drugs in Late-Stage Development for the Treatment of Multiple Sclerosis: A Focus on Oral Synthetic Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
Current Genomics Highlights on Important Medicinal Plants for the Menopause Syndrome
Current Women`s Health Reviews Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Development and Validation of a Stability-Indicating HPLC Method for the Assay of Carvedilol in Pure and Tablet Dosage Forms
Current Pharmaceutical Analysis Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews Improving Antihypertensive Agent Selection to Promote Nephroprotection
Current Hypertension Reviews